C. Clark

发表

The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence

C. Maas, S. de Maat, W. Sanrattana, 2020, Thrombosis and Haemostasis.

A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation

C. Maas, M. Maurer, J. Scheffel, 2019, The Journal of Biological Chemistry.

Targeted SERPIN (TaSER): A dual‐action antithrombotic agent that targets platelets for SERPIN delivery

T. Renné, C. Maas, M. Roest, 2021, Journal of thrombosis and haemostasis : JTH.

Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.

T. Renné, C. Maas, P. Lenting, 2021, Blood.

Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma

C. Maas, B. Hazenberg, P. D. de Groot, 2018, Thrombosis and Haemostasis.

Factor XII truncation accelerates activation in solution

C. Maas, S. de Maat, W. Sanrattana, 2018, Journal of thrombosis and haemostasis : JTH.

Detecting oral kallikrein-targeting therapy through triggered contact activation: a phase I study.

C. Maas, C. Hack, S. de Maat, 2020, The Journal of allergy and clinical immunology.

Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department

C. Maas, A. Slooter, L. Koenderman, 2023, BMC Emergency Medicine.

Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity

C. Maas, M. Boes, L. Koenderman, 2022, Frontiers in Medicine.

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood

C. Maas, R. Urbanus, P. Boross, 2019, Scientific Reports.

An increase in CD62Ldim neutrophils precedes the development of pulmonary embolisms in COVID‐19 patients

C. Maas, A. Slooter, L. Koenderman, 2021, Scandinavian journal of immunology.